BY CHRISTIAN BUNDGAARD
-
Analysis: Danish life science companies want to reduce remote work in the future
Although research shows that life science companies want employees to physically return to the office, the picture is not as clear when asking companies directly.
-
Eli Lilly: New head-to-head trial data provides better conditions for doctors
Eli Lilly’s elderly clinical supervisor for Nordic nations assumes that the brand-new neck and neck research makes it simpler for physicians to suggest either Lilly’s o…
-
Eli Lilly study concludes: Tirzepatide is better for weight loss than Novo Nordisk’s semaglutide
Generally, tirzepatide created a 47% better family member weight management contrasted to semaglutide, according to Eli Lilly.
-
Jefferies doubts Wegovy heir’s sales prospects
Novo Nordisk deals with a vast array of obstacles related to cagrisema, claims expert.
-
WS Audiology reports large bottom-line loss despite organic growth of 10%
The listening devices business takes a success under line with a one-off loss of EUR 1.2 bn because of modifications in devaluation technique. Nevertheless, the business sheds cash…
-
WS Audiology reports large bottom-line loss despite organic growth of 10%
The hearing aid company takes a big hit on the bottom line with a one-off loss of EUR 1.2bn due to changes in depreciation method. However, the company loses money regardless.
-
Europe is lagging behind in R&D investment
China and the United States invest much more cash on r & d, triggering entrance hall to recommend that Europe increase its passions also better.
-
WS Audiology reports large bottom-line loss despite organic growth of 10%
The listening device firm takes a success under line with a one-off loss of EUR 1.2 bn as a result of adjustments in devaluation technique. Nonetheless, the firm sheds cash no matt…
-
Novo Nordisk has obtained lab monkeys from disreputable farms
Novo Nordisk’s laboratory apes can just originate from 3 ranches in Vietnam, professionals claim. All 3 are implicated of acquiring apes from the underground market. Novo Nor…
-
Freya Biosciences discloses investment sum from Bill Gates Foundation
The quantity brings Freya Bioscience’s very first Collection A to around USD 50m.
